Skip to content

Clinical trials

Phase 2/3 Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2/3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20122
20142
20151
20162
20183
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status4
Recruiting2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeuroVita Clinic2
AHS Cancer Control Alberta1
Alpha Biopharma (Jiangsu) Co., Ltd.1
Amsterdam UMC, location VUmc1
Blaze Bioscience Inc.1
Cancer Research UK1
Chang Gung Memorial Hospital1
Shanghai Chest Hospital1
Sun Yat-sen University1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms15
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms3
Glioma2
Medulloblastoma2
Neoplasm Metastasis2
Neoplasms2
Breast Neoplasms1
Central Nervous System Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.